This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Garcha, H.S. Articles by Stolerman, I.P. Search for Related Content PubMed Articles by Garcha, H.S. Articles by Stolerman, I.P. Social Bookmarking                   What's this?

Discriminative stimulus effects of the nicotine antagonist mecamylamine in rats

Department of Psychiatry, Institute of Psychiatry, De Crespigny Park, London SE5 8AF, UK

I.P. Stolerman

Department of Psychiatry, Institute of Psychiatry, De Crespigny Park, London SE5 8AF, UK

The discriminative stimulus effects of the nicotine antagonist mecamylamine have been investigated to characterize further its behavioural effects and its interactions with (-)-nicotine. Rats were trained to discriminate the effects of mecamylamine from saline in a two-bar operant conditioning procedure with food reinforcers presented on a tandem schedule of reinforcement. Mecamylamine (3.5 mg/kg s.c.) acquired strong stimulus control over behaviour and there was only a small reduction in overall rates of responding. The mecamylamine stimulus generalized completely to some ganglion-blocking drugs (order of relative potency: pentolinium > mecamylamine > pempidine) but it did not generalize to other ganglion-blockers (hexamethonium, trimetaphan and chlorisondamine). The mecamylamine stimulus also failed to generalize to (-)-nicotine, to muscarinic antagonists (atropine and scopolamine) or to excitatory amino acid antagonists (dizocilpine, phencyclidine and D-CPPene). Mecamylamine, pempidine, hexamethonium, trimetaphan, (-)-nicotine, scopolamine, phencyclidine, dizocilpine and D-CPPene were tested up to doses that reduced overall rates of responding. Tests also showed that (-)-nicotine did not antagonize the response to mecamylamine. The discriminative stimulus produced by mecamylamine may originate at nicotinic receptors but whether these are located centrally or peripherally is unclear. There was no evidence that either muscarinic or excitatory amino acid receptors were involved in mediating the effect.

Key Words: drug discrimination • mecamylamine • ganglion blockers • muscarinic antagonists • nicotine • excitatory amino acid antagonists

Journal of Psychopharmacology, Vol. 7, No. 1 suppl, 43-51 (1993)
DOI: 10.1177/026988119300700108


CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?